首页> 外文期刊>JAMA: the Journal of the American Medical Association >Children, asthma, and proton pump inhibitors: costs and perils of therapeutic creep.
【24h】

Children, asthma, and proton pump inhibitors: costs and perils of therapeutic creep.

机译:儿童,哮喘和质子泵抑制剂:治疗性蠕变的成本和风险。

获取原文
获取原文并翻译 | 示例
       

摘要

CHILDREN WITH ASTHMA REPORT SYMPTOMS OF GAS-troesophageal reflux disease (GERD) more often than children without asthma. Nevertheless, a systematic review of the child health literature, which included studies using pH probes and other objective assessment methods, concluded that the true nature of the association between GERD and asthma, their temporal relation, and the causal direction, remain unknown. Moreover, the potential for antiacid therapy to improve asthma symptoms in children with poorly controlled disease remains largely anecdotal. A small, randomized placebo-controlled trial showed no improvement in asthma status among children treated with omeprazole for 12 weeks.
机译:患有哮喘的儿童报告气管食管反流病(GERD)的症状要多于没有哮喘的儿童。然而,对儿童健康文献的系统综述,包括使用pH探针和其他客观评估方法的研究,得出的结论是,GERD与哮喘之间关联的真实性质,它们的时间关系和因果关系仍然未知。此外,抗酸疗法改善疾病控制不佳儿童哮喘症状的潜力仍然很大。一项小型的随机安慰剂对照试验显示,用奥美拉唑治疗12周的儿童,哮喘状态没有改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号